Compare PHAR & VREX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PHAR | VREX |
|---|---|---|
| Founded | 1988 | 2016 |
| Country | Netherlands | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Industrial Machinery/Components |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.2B | 501.8M |
| IPO Year | 2020 | 2016 |
| Metric | PHAR | VREX |
|---|---|---|
| Price | $13.59 | $10.14 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 3 | 3 |
| Target Price | ★ $38.33 | $16.67 |
| AVG Volume (30 Days) | 12.2K | ★ 473.0K |
| Earning Date | 05-07-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $811,000,000.00 |
| Revenue This Year | $10.04 | $5.35 |
| Revenue Next Year | $2.51 | $3.88 |
| P/E Ratio | $3,041.22 | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $9.54 | $6.76 |
| 52 Week High | $21.34 | $14.57 |
| Indicator | PHAR | VREX |
|---|---|---|
| Relative Strength Index (RSI) | 41.99 | 43.31 |
| Support Level | $12.98 | $10.04 |
| Resistance Level | $13.44 | $12.44 |
| Average True Range (ATR) | 0.53 | 0.60 |
| MACD | 0.07 | 0.01 |
| Stochastic Oscillator | 83.60 | 31.51 |
Pharming Group is a biotechnology company focused on developing and commercializing therapies for rare and ultra-rare diseases, particularly immunological and genetic conditions with high unmet need. It operates as an integrated company with capabilities across clinical development, manufacturing, regulatory affairs, and commercialization, supported by scientific and operational expertise. It leverages its efficient infrastructure to expand its pipeline and improve patient access to treatment. The Company operates in the United States, Europe, and the rest of the world, with the United States contributing the majority of its revenue.
Varex Imaging Corp Designs, manufactures, sells, and services X-ray imaging components, including X-ray tubes, detectors, ionization chambers, high-voltage connectors, software, collimators, generators, exposure control devices, and heat exchangers.. The company operates through two segments: Medical, the key revenue driver, providing X-ray imaging components and accessories for healthcare applications, and Industrial, which provides Linatron X-ray accelerators, X-ray tubes, flat panel detectors, high-voltage connectors, and coolers for non-medical use. Geographically, it generates the majority of its revenue from Europe, the Middle East, and Africa (EMEA), with the rest coming from the Americas and Asia Pacific.